EN
HI
Summary
As of 30 Aug, 2026, Gland Pharma stock price is ₹2888. During the trading session, the stock has moved between an intraday low of ₹2852.10 and an intraday high of ₹2900.00. Over the last 52 weeks, Gland Pharma has traded between ₹1573.60 and ₹3039.80.
The stock has recorded a trading volume of 1,65,191 shares, with a market capitalization of ₹164959682. Its Average Traded Price (ATP) is ₹2883.24, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹2888.00.
Gland Pharma has an upper circuit limit of ₹3465.60 and a lower circuit limit of ₹2310.40. The total value traded stands at ₹47.63 CR, and the delivery percentage for the day is 47.21%.
The stock is currently traded with a market lot size of 1. Gland Pharma also offers a dividend yield of 0.69%.
Gland Pharma share price chart
Gland Pharma Share Key Metrics
Volume
1.65 L
Market Cap
47640.36 CR
LTQ@LTP
1@2888.00
ATP
2883.24
Var Margin
17.34 %
Circuit Range
2310.4-3465.6
Delivery %
47.21 %
Value
47.63 CR
ASM/GSM
No
Market Lot
1
Gland Pharma Fundamentals
P/E Ratio
42.18
P/B Ratio
4.48
Div. Yield
0.69
Sector P/E
69.42
Sector P/B
3.5
Sec. Div. Yield
0.51
Gland Pharma Resistance and Support
Pivot 2884.5
Resistance
First Resistance
2913.4
Second Resistance
2953.3
Third Resistance
2982.2
Support
First Support
2844.6
Second Support
2815.7
Third Support
2775.8
Gland Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 28 2026 | 2873.5 | 2888 | 0.50% | 2900 | 2852.1 |
| Thu Aug 27 2026 | 2912.89 | 2873.5 | -1.02% | 2924.39 | 2855.6 |
| Wed Aug 26 2026 | 2838.69 | 2903.19 | 2.78% | 2915 | 2831.39 |
Gland Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-05-15 | Audited Results & Final Dividend |
| 2026-01-28 | Quarterly Results |
| 2025-11-03 | Quarterly Results |
| 2025-08-05 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results |
| 2024-11-04 | Quarterly Results |
| 2024-08-06 | Quarterly Results |
Gland Pharma News
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Gland Pharma has scheduled one-on-one investor meetings with institutional investors. The company will meet Nomura on August 26, 2026, and HDFC MF on August 27, 2026, to engage with the investment community.
Aug 23 2026 09:38:20
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in Management
Gland Pharma appointed Mr. Deepak Sapra as its new Chief Executive Officer (CEO). He will assume the role on November 16, 2026, bringing extensive experience in the pharmaceutical industry.
Aug 14 2026 08:44:34
Read More
Gland Pharma Management
| Name | Position |
|---|---|
| Sampath Kumar Pallerlamudi | Company Secretary & Compliance Officer |
| Srinivas Sadu | Chairman |
Gland Pharma Similar Stocks
Alkem Laboratories Ltd.
5355.00
35.00 (0.66%)
Abbott India Ltd.
26175.00
-175.00 (0.66%)
Anthem Biosciences Ltd.
900.10
-24.50 (2.65%)
Glaxosmithkline Pharmaceuticals Ltd.
3106.40
37.30 (1.22%)
Ipca Laboratories Ltd.
1950.30
-9.50 (0.48%)
Ajanta Pharma Ltd.
3557.00
13.40 (0.38%)
Global Health Ltd.
1472.20
-36.70 (2.43%)
Narayana Hrudayalaya Ltd.
1932.10
28.30 (1.49%)
Gland Pharma FAQs
The Buying Price of Gland Pharma share is 2888 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Gland Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gland Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Gland Pharma shares is 42.18. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Gland Pharma shares is 4.48. Useful to assess the stock's value relative to its book value.
To assess Gland Pharma’s valuation compare Sector P/E, P/B which are 69.42 & 3.5 with sector averages, along with growth rates and financial metrics.
The Market Cap of Gland Pharma is 47640.36 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Gland Pharma share price is 3039.80 & 1573.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Gland Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
